NCT02063139View on ClinicalTrials.gov

Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

January 31, 2015

Conditions

Mild Persistent Asthma

Interventions

DRUG

Flutiform 50/5 ug (2 puffs bid) pMDI

DRUG

Fluticasone 50 ug (2puffs bid) pMDI

DRUG

Beclometasone Autohaler 50 ug (2 puffs bid)

Trial Locations (1)

Unknown

Asthma and Allergy Children's Clinic, Randers

All Listed Sponsors

lead

Mundipharma Research Limited

INDUSTRY

NCT02063139 - Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. | Biotech Hunter | Biotech Hunter